Blood pressure lowering effect of one compound tablet replacement as two tablets of angiotensin 2 receptor blocker(ARB) and calcium channel blocker(CCB) - ECO Tablet trial

Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 sites200 target enrollmentAugust 1, 2012

Conditionsthe hypertensive patient who has taken ARB and CCB

Overview

Phase: 未知
Intervention: Not specified
Conditions: the hypertensive patient who has taken ARB and CCB
Sponsor: Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Enrollment: 200
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

August 1, 2012

End Date

October 31, 2015

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•a) patient with previous allergic reaction to azelnidipine or olmesartan. b) female patient who has possibility of pregnancy. c) patient treated with azole antifungal drug or HIV protease inhibitor. d) patient who has taken hemodialysis or has severe renal dysfunction (serume creatine level is above 2\.0mg/dL). e) patient considered to be improper to this study by attending doctor.